| pharmacogenomics |
Pharmacogenomics is the branch of pharmaceutics which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. By doing so, pharmacogenomics aims to develop rational means to optimise drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. ...
출처: en.wikipedia.org/wiki/Pharmacogenomics
|
|---|---|
| pharmacogenomics |
The study of how and which variations in the human genome affect the response to medications.
출처: www.nature.com/nrg/journal/v5/n4/glossary/nrg1317_...
|
| pharmacogenomics |
The evaluation of individual genomic variation in relation to the delivery and effectiveness of drugs. Knowledge of individual genotype and hence phenotype makes it possible to customize drugs and drug delivery methods for specific subgroups.
출처: www.genpromag.com/Glossary~LETTER~P.html
|
| pharmacogenomics |
Study of genetic variation underlying differential response to drugs.
출처: science.education.nih.gov/supplements/nih1/genetic...
|
| pharmacogenomics |
The science of understanding the correlation between an individual patient's genetic make-up (genotype) and their response to drug treatment. Some drugs work well in some patient populations and not as well in others. Studying the genetic basis of patient response to therapeutics allows drug developers to more effectively design therapeutic treatments.
출처: www.food.gov.uk/science/ouradvisors/toxicity/cotme...
|